SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kilpest India informs about business update

01 Jun 2021 Evaluate

Kilpest India has informed that the company has sold 13,19,000 COVID-19 RT-PCR Tests in the month of May, 2021 with an average price of Rs 78 per test. Also Exports against Licenses received worth Rs 8,58,000 was done in May, 2021. The amalgamation application after vetting has been uploaded by BSE on 31/05/21, due to COVID-19 lockdowns some delay occurred, now things should get processed faster, with SEBI approval and thereafter NCLT approval. Company will go for NSE listing, once the amalgamated company is formed after all approvals. The COVID-19 Antigen Test Kit is in advanced stage of development.

The above information is a part of company’s filings submitted to BSE.

3B Blackbio Dx Share Price

1309.90 63.60 (5.10%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Lenskart Solutions 534.85
Poly Medicure 1468.25
Laxmi Denta 195.10
Nureca Ltd. 263.80
Hemant Surgical Inds 297.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×